Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Bellis

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Internal and Emergency Medicine|June 25, 2009
Clinical trials in heart failure: may we trust?Bruno Trimarco, Alessandro Bellis
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 23, 2013
Pharmacological approach to cardiovascular risk in metabolic syndromeAlessandro Bellis, Bruno Trimarco
Giornale Italiano Di Cardiologia (2006)|April 4, 2008
[Renin-angiotensin system modulation: instructions for use]Alessandro Bellis, Francesco Rozza, Salvatore Crispo, et al.
ESC Heart Failure|September 20, 2022
The PARADISE-MI trial: a new opportunity to improve the left ventricular remodelling in reperfused STEMIAlessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
International Journal of Molecular Sciences|November 18, 2020
The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19Alessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|October 4, 2024
PCSK9 Inhibitors: Is the Time Ripe for the "Fast Track" Use Independently on the LDL-C Baseline Values in Acute Coronary Syndrome?Alessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
International Journal of Molecular Sciences|January 20, 2021
Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic PerspectivesAlessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
Cells|September 24, 2020
The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial InfarctionAlessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
Circulation Research|December 14, 2004
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytesCarmine Morisco, Gerolama Condorelli, Valentina Trimarco, et al.
Journal of Clinical Medicine|July 19, 2021
Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic StrategyAlessandro Bellis, Giuseppe Di Gioia, Ciro Mauro, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Internal and Emergency Medicine|June 25, 2009
Clinical trials in heart failure: may we trust?Bruno Trimarco, Alessandro Bellis
Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 23, 2013
Pharmacological approach to cardiovascular risk in metabolic syndromeAlessandro Bellis, Bruno Trimarco
Giornale Italiano Di Cardiologia (2006)|April 4, 2008
[Renin-angiotensin system modulation: instructions for use]Alessandro Bellis, Francesco Rozza, Salvatore Crispo, et al.
ESC Heart Failure|September 20, 2022
The PARADISE-MI trial: a new opportunity to improve the left ventricular remodelling in reperfused STEMIAlessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
International Journal of Molecular Sciences|November 18, 2020
The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19Alessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|October 4, 2024
PCSK9 Inhibitors: Is the Time Ripe for the "Fast Track" Use Independently on the LDL-C Baseline Values in Acute Coronary Syndrome?Alessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
International Journal of Molecular Sciences|January 20, 2021
Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic PerspectivesAlessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
Cells|September 24, 2020
The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial InfarctionAlessandro Bellis, Ciro Mauro, Emanuele Barbato, et al.
Circulation Research|December 14, 2004
Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytesCarmine Morisco, Gerolama Condorelli, Valentina Trimarco, et al.
Journal of Clinical Medicine|July 19, 2021
Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic StrategyAlessandro Bellis, Giuseppe Di Gioia, Ciro Mauro, et al.
Pageof 3